drug toxicity testing TwinStrand Biosciences Explores Error Reduction Sequencing Tech in Various Applications Premium Since the commercial launch of its technology last year, the firm has been validating it in studies with academic groups and pharmaceutical companies. European Clinics Evaluating New Card System for Making PGx Data Available to Patients Premium The system relies on the use of scannable safety code cards containing patient data, along with a web portal and automated analysis tools that deliver customized diagnostic reports. Weill Cornell Builds PGx Database for Chemotherapy-Induced Cardiotoxicity Premium The CATCH-KB database is a standardized variant repository meant to support new research into prevention of chemotherapy-induced cardiotoxicity. Canada's Cyclica Targets Pharma with Drug-Protein Interaction Search Software Premium The company's Ligand Express software combines biological, chemical, and protein structure data to identify candidate molecules for further research and development. Agilent, Illumina Sponsor Alliance Established for Toxicity Testing Using Integrated Systems Biology NEW YORK (GenomeWeb News) – The Hamner Institutes for Health Sciences has established a pre-competitive partnership with several organizations to advance an integrated systems biology approach to toxicity testing research. Sep 19, 2012 GGA to Curate Data from Pharma Toxicity Project Sep 16, 2011 NIH, FDA, DARPA to Fund Development of Chip for Drug Safety Assessment Apr 8, 2011 Tox21 Prepares to Launch Phase II of Chemical Screening Effort Feb 17, 2011 CIT, Stemina Ink Distribution Deal for Stem Cell-based Assay Oct 23, 2009 EMD Chemicals, MitoSciences to Co-develop Assays Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.